By Josh White
Date: Thursday 12 Dec 2024
LONDON (ShareCast) - (Sharecast News) - Heat treatment and specialist thermal processing specialist Bodycote unveiled a strategy to drive growth, operational performance and sustainability on Thursday.
The FTSE 250 company, which was holding a capital markets event, said it had restructured its operations into two core divisions - specialist technologies, which includes differentiated offerings like hot isostatic pressing (HIP) and surface technologies; and precision heat treatment, focused on optimising global plant operations.
Reporting under the new framework would start in 2025.
Bodycote said it had identified three strategic levers - 'optimise', 'perform', and 'grow' - to enhance efficiency, elevate service quality, and accelerate growth.
The board said the initiatives included streamlining its plant network, implementing a performance improvement programme, and expanding into structural growth markets and faster-growing geographies.
It also highlighted its role in enabling customers to reduce carbon emissions, aligning with broader sustainability goals.
New financial targets included mid-single-digit percentage annual revenue growth, increasing specialist Technologies' share of revenue to between 35% and 40% by 2028, and achieving operating margins above 20% by the same year.
Bodycote said it was also aiming for operating cash conversion of 80% to 90% and a return on capital employed of 15% to 20% through the cycle.
The company also announced a £30m extension to its existing £60m share buyback programme.
Net debt stood at £70m as of 31 October, equating to a leverage ratio of about 0.45x net debt-to-EBITDA.
The company said sustainability remained central to its strategy, noting that it had committed to reducing absolute scope one and two greenhouse gas emissions by 46% by 2030 compared to 2019 levels, aligning with science-based targets.
It also aimed to increase revenue from sustainable end-use markets to 20% by 2035, up from 7% in 2023.
Optimisation efforts were expected to deliver an annual operating profit uplift of £12m to £14m by the end of 2026, though they would incur exceptional costs of about £60m.
Despite the one-off expenses, Bodycote reaffirmed its confidence in achieving its long-term objectives.
The board said current trading remained consistent with the company's November update, with full-year expectations unchanged.
"Today we are presenting a clear vision to create an optimised, efficient and high-performance Bodycote, which will deliver sustainably stronger growth with improved profitability and resilience through the cycle," said chief executive officer Jim Fairbairn.
"We are establishing a set of compelling and achievable financial targets.
"We are confident in our ability to achieve these ambitions and have a clear plan to deliver on our targets."
Fairbairn said that would benefit both shareholders as well as Bodycote's people, customers and partners.
"We are building a company that can fully realise its potential, and ensure that Bodycote's excellence endures long into the future."
At 0900 GMT, shares in Bodycote were up 0.15% at 665p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 659.00p |
Change Today | -19.50p |
% Change | -2.87 % |
52 Week High | 691.50p |
52 Week Low | 460.60p |
Volume | 145,972 |
Shares Issued | 175.70m |
Market Cap | £1,157.86m |
RiskGrade | 147 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 02-Oct-25 | 24-Apr-25 |
Paid | 06-Nov-25 | 05-Jun-25 |
Amount | 6.90p | 16.10p |
Time | Volume / Share Price |
16:28 | 7 @ 660.00p |
16:22 | 2 @ 660.00p |
16:27 | 21 @ 660.50p |
16:27 | 41 @ 660.50p |
16:27 | 27 @ 661.00p |
You are here: research